{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:31:43Z","timestamp":1780583503829,"version":"3.54.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6407","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T18:17:14Z","timestamp":1472667434000},"page":"2379-2385","source":"Crossref","is-referenced-by-count":10,"title":["Management of Adult Chronic Immune Thrombocytopenia in Japan: Patient and Hematologist Perspectives from a Multi-center Cross-sectional Questionnaire Survey"],"prefix":"10.2169","volume":"55","author":[{"given":"Yutaka","family":"Tsukune","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cines DB, Bussel JB, McMillan RB, Zehnder JL. Congenital and acquired thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2004: 390-406.","DOI":"10.1182\/asheducation-2004.1.390"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. McMillan R, Durette C. Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 104: 956-960, 2004.","DOI":"10.1182\/blood-2003-11-3908"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115: 168-186, 2010.","DOI":"10.1182\/blood-2009-06-225565"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 346: 995-1008, 2002.","DOI":"10.1056\/NEJMra010501"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4: 1664-1672, 2006.","DOI":"10.1111\/j.1538-7836.2006.02013.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386-2393, 2009.","DOI":"10.1182\/blood-2008-07-162503"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mathias SD, Gao SK, Miller KL, et al. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 6: 13, 2008.","DOI":"10.1186\/1477-7525-6-13"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126: 307-314, 1997.","DOI":"10.7326\/0003-4819-126-4-199702150-00007"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117: 4190-4207, 2011.","DOI":"10.1182\/blood-2010-08-302984"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rodeghiero F, Besalduch J, Michel M, Provan D, Grotzinger K, Thompson G. Treatment practices in adults with chronic immune thrombocytopenia: a European perspective. Eur J Haematol 84: 160-168, 2010.","DOI":"10.1111\/j.1600-0609.2009.01361.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shiota S, Murakami K, Fujioka T, Yamaoka Y. Population-based strategies for <i>Helicobacter pylori<\/i>-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol 4: 149-156, 2010.","DOI":"10.1586\/egh.10.7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Stasi R, Provan D. <i>Helicobacter pylori<\/i> and chronic ITP. Hematology Am Soc Hematol Educ Program. 2008: 206-211.","DOI":"10.1182\/asheducation-2008.1.206"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Campuzano-Maya G. Proof of an association between <i>Helicobacter pylori<\/i> and idiopathic thrombocytopenic purpura in Latin America. Helicobacter 12: 265-273, 2007.","DOI":"10.1111\/j.1523-5378.2007.00502.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in <i>Helicobacter pylori<\/i>-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 81: 162-168, 2005.","DOI":"10.1532\/IJH97.04146"},{"key":"15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","volume":"352","author":"A Gasbarrini","year":"1998","unstructured":"15. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of <i>Helicobacter pylori<\/i>. Lancet 352: 878, 1998.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Inaba T, Mizuno M, Take S, et al. Eradication of <i>Helicobacter pylori<\/i> increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 35: 214-219, 2005.","DOI":"10.1111\/j.1365-2362.2005.01471.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. <i>Helicobacter pylori<\/i> eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118: 414-419, 2005.","DOI":"10.1016\/j.amjmed.2004.09.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Suzuki T, Matsushima M, Masui A, et al. Effect of <i>Helicobacter pylori<\/i> eradication in patients with chronic idiopathic thrombocytopenic purpura: a randomized controlled trial. Am J Gastroenterol 100: 1265-1270, 2005.","DOI":"10.1111\/j.1572-0241.2005.41641.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kuter DJ, Mathias SD, Rummel M, et al. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. Am J Hematol 87: 558-561, 2012.","DOI":"10.1002\/ajh.23163"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mathias SD, Gao SK, Rutstein M, Snyder CF, Wu AW, Cella D. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. Cur Med Res Opin 25: 375-383, 2009.","DOI":"10.1185\/03007990802634119"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 83: 150-154, 2008.","DOI":"10.1002\/ajh.20992"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin 24: 2767-2776, 2008.","DOI":"10.1185\/03007990802377461"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/17\/55_55.6407\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:45:46Z","timestamp":1498326346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/17\/55_55.6407\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6407","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}